Blood Diseases Market Research Reports & Industry Analysis

Global Hematologic Malignancies Databank Market Report The Hematologic Malignancies market was valued at $39,152.3 Million in 2020, and is projected to reach $82,527.1 Million by 2029 growing at a CAGR of 8.69% from 2021 to 2029. Leukemia segment is expected to be the highest contributor to this mar ...

Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutat ...

Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two type ...

Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of he ...

Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There ...

Hemophilia Gene Therapy Industry Research Report 2024 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes th ...

Global Thalassemia Market - 2024-2031 Global Thalassemia Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing with a CAGR of XX % during the forecast period 2024-2031. Thalassemia represents a substantial health burden, particularly in regions where the prev ...

Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and ...

Global chemotherapy-induced thrombocytopenia Market - 2023-2030 The global chemotherapy-induced thrombocytopenia market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030. Chemotherapy-induced thrombocytopen ...

Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ...

Anemia Associated with Chronic Kidney - Pipeline Insight, 2024 Anemia Associated with Chronic Kidney Overview ""Anemia Associated with Chronic Kidney Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ...

Global Anemia Treatment Drugs Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Anemia Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Anemia Treatment Drugs is forecast to a readju ...

Global Alpha Thalassemia Treatment Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Alpha Thalassemia Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Alpha Thalassemia Treatment is forec ...

Global Iron Deficiency Anemia Drug Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Iron Deficiency Anemia Drug market size was valued at US$ 1665 million in 2023. With growing demand in downstream market, the Iron Deficiency Anemia Drug is ...

Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Iron Deficiency Anemia, Sickle Cell Anemia, Pernicious Anemia, Hemolytic Anemia), By Application (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Anemia Therapeutics market size is p ...

Renal Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Intravenous, Oral), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Renal Anemia Therapeutics market size is poised to registe ...

Thalassemia Drugs Market Size, Trends, Analysis, and Outlook By Type (Alpha Thalassemia Drugs, Beta Thalassemia Drugs), By Treatment (Iron Chelation Therapy, Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Retail Pharmacies, Others), by Region, Country, Segment, and Companie ...

Stem Cell Umbilical Cord Blood Market Size, Trends, Analysis, and Outlook By Storage Serivces (Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks), By Therapeutics (Cancer, Diabetes, Blood diseases, Immune Disorders, Metabolic Disorders, Others), By Application (Transplant Me ...

Autoimmune Hemolytic Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Corticosteroids, Monoclonal Antibodies, Others), By Route of Administration (Oral, Injectable), By Therapy (First Line Therapy, Second Line Therapy, Third Line Therapy), By Distribution Channel (Hospit ...

Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, ...

Cancer Supportive Care Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Chemotherapy-Induced Anemia, Chemotherapy-Induced Neutropenia, Cancer Pain, Cinv, Others), By Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Providers), by Region, Country, S ...

Hemoglobinopathies Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, Others), By Application (Thalassemia, Sickle Cell Anaemia, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Hemoglobinopathies ...

Bone Marrow Transplant Market Size, Trends, Analysis, and Outlook By Treatment (Myelodysplastic Syndrome, Myeloproliferative neoplasms, Leukemia, Lymphoma, Aplastic Anemia, Myeloma, Solid Tumors, Sickle Cell Anemia, Thalassemia, Others), By End-User (Hospitals, Multi-Specialty Clinics, Ambulatory Su ...

Hemophilia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replace ...

Beta Thalassemia Market Assessment, By Type [Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major], By Therapy [Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy, Bone Marrow Transplants], By Distribution Channel [Hospital Pharmacies, Retail Phar ...